Abstract
Although the trans-translation system is a promising target for antcibiotic development, its antibacterial mechanism in Klebsiella pneumoniae (KP) is unclear. Considering that tmRNA was the core component of trans-translation, this study firstly investigated phenotypic changes caused by various environmental stresses in KP lacking trans-translation activities (tmRNA-deleted), and then aimed to evaluate antibacterial activities of the trans-translation-targeting antibiotic combination (tobramycin/ciprofloxacin) in clinical KP isolates based on inhibition activities of aminoglycosides against trans-translation. We found that the tmRNA-deleted strain P4325/ΔssrA was significantly more susceptible than the wild-type KP strain P4325 under environments with hypertonicity (0.5 and 1 M NaCl), hydrogen peroxide (40 mM), and UV irradiation. No significant differences in biofilm formation and survivals under human serum were observed between P4325/ΔssrA and P4325. tmRNA deletion caused twofold lower MIC values for aminoglycosides. As for the membrane permeability, tmRNA deletion increased ethidium bromide (EtBr) uptake of KP in the presence or absence of verapamil and carbonyl cyanide-m-chlorophenylhydrazone (CCCP), decreased EtBr uptake in presence of reserpine in P4325/ΔssrA, and reduced EtBr efflux in P4325/ΔssrA in the presence of CCCP. The time-kill curve and in vitro experiments revealed significant bactericidal activities of the tmRNA-targeting aminoglycoside-based antibiotic combination (tobramycin/ciprofloxacin). Thus, the corresponding tmRNA-targeting antibiotic combinations (aminoglycoside-based) might be effective and promising treatment options against multi-drug resistant KP.
Similar content being viewed by others
Data availability
The data underlying this article will be shared on reasonable request to the corresponding authors.
References
Albarri O, AlMatar M, Öcal MM, Köksal F (2022) Overexpression of efflux pumps AcrAB and OqxAB contributes to ciprofloxacin resistance in clinical isolates of K. pneumonia. Curr Protein Pept Sci 23(5):356–368. https://doi.org/10.2174/1389203723666220630162920
Aron ZD, Mehrani A, Hoffer ED, Connolly KL, Srinivas P, Torhan MC et al (2021) Trans-translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo. Nat Commun 12(1):1799. https://doi.org/10.1038/s41467-021-22012-7
Ballén V, Gabasa Y, Ratia C, Ortega R, Tejero M, Soto S (2021) Antibiotic resistance and virulence profiles of Klebsiella pneumoniae strains isolated from different clinical sources. Front Cell Infect Microbiol 11:738223. https://doi.org/10.3389/fcimb.2021.738223
Bazzaz BSF, Fakori M, Khameneh B, Hosseinzadeh H (2019) Effects of omeprazole and caffeine alone and in combination with gentamicin and ciprofloxacin against antibiotic resistant Staphylococcus aureus and Escherichia coli strains. J Pharmacopuncture 22(1):49–54. https://doi.org/10.3831/KPI.2019.22.006
Brito L, Wilton J, Ferrándiz MJ, Gómez-Sanz A, de la Campa AG, Amblar M (2017) Absence of tmRNA has a protective effect against fluoroquinolones in Streptococcus pneumoniae. Front Microbiol 7:2164. https://doi.org/10.3389/fmicb.2016.02164
Brunel R, Descours G, Durieux I, Doublet P, Jarraud S, Charpentier X (2018) KKL-35 Exhibits potent antibiotic activity against Legionella species independently of trans-translation inhibition. Antimicrob Agents Chemother 62(2):e01459–e01517. https://doi.org/10.1128/AAC.01459-17
Campos-Silva R, D’Urso G, Delalande O, Giudice E, Macedo AJ, Gillet R (2021) Trans-translation is an appealing target for the development of new antimicrobial compounds. Microorganisms 10(1):3. https://doi.org/10.3390/microorganisms10010003
Corvaisier S, Bordeau V, Felden B (2003) Inhibition of transfer messenger RNA aminoacylation and trans-translation by aminoglycoside antibiotics. J Biol Chem 278(17):14788–14797. https://doi.org/10.1074/jbc.M212830200
Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L et al (2018) A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 18(1):37–46. https://doi.org/10.1016/S1473-3099(17)30489-9
Halpern D, Gruss A, Claverys JP, Karoui ME (2004) rexAB mutants in Streptococcus pneumoniae. Microbiology 150(Pt 7):2409–2414. https://doi.org/10.1099/mic.0.27106-0
Ham SY, Kim HS, Jo MJ, Lee JH, Byun Y, Ko GJ et al (2021) Combined treatment of 6-gingerol analog and tobramycin for inhibiting Pseudomonas aeruginosa infections. Microbiol Spectr 9(2):e0019221. https://doi.org/10.1128/Spectrum.00192-21
Hu F, Zhu D, Wang F, Jiang X, Sun Z, Chen Z et al (2014) CHINET 2013 surveillance of bacterial resistance in China. Chin J Infect Chemother 14:365–374
Hurdle JG, O’Neill AJ, Chopra I, Lee RE (2011) Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol 9(1):62–75. https://doi.org/10.1038/nrmicro2474
Janssen BD, Hayes CS (2012) The tmRNA ribosome-rescue system. Adv Protein Chem Struct Biol 86:151–191. https://doi.org/10.1016/B978-0-12-386497-0.00005-0
Julio SM, Heithoff DM, Mahan MJ (2000) ssrA (tmRNA) plays a role in Salmonella enterica serovar typhimurium pathogenesis. J Bacteriol 182(6):1558–1563. https://doi.org/10.1128/JB.182.6.1558-1563.2000
Keiler KC (2015) Mechanisms of ribosome rescue in bacteria. Nat Rev Microbiol 13(5):285–297. https://doi.org/10.1038/nrmicro3438
Keiler KC, Alumasa JN (2013) The potential of trans-translation inhibitors as antibiotics. Future Microbiol 8(10):1235–1237. https://doi.org/10.2217/fmb.13.110
Lam SJ, O’Brien-Simpson NM, Pantarat N, Sulistio A, Wong EH, Chen YY et al (2016) Combating multidrug-resistant gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers. Nat Microbiol 1(11):16162. https://doi.org/10.1038/nmicrobiol.2016.162
Ma X, Fu S, Wang Y, Zhao L, Yu W, He Y et al (2022) Proteomics study of the synergistic killing of tigecycline in combination with aminoglycosides against carbapenem-resistant Klebsiella pneumoniae. Front Cell Infect Microbiol 12:920761. https://doi.org/10.3389/fcimb.2022.920761
Mu X, Huan H, Xu H, Gao Q, Xiong L, Gao R et al (2013) The transfer-messenger RNA-small protein B system plays a role in avian pathogenic Escherichia coli pathogenicity. J Bacteriol 195(22):5064–5071. https://doi.org/10.1128/JB.00628-13
Na IY, Chung ES, Jung CY, Kim DH, Shin J, Kang K et al (2016) Comparison of the virulence-associated phenotypes of five species of Acinetobacter baumannii complex. J Microbiol Biotechnol 26(1):171–179. https://doi.org/10.4014/jmb.1507.07076
Naclerio GA, Onyedibe KI, Sintim HO (2020) Lipoteichoic acid biosynthesis inhibitors as potent inhibitors of S. aureus and E. faecalis growth and biofilm formation. Molecules 25(10):2277. https://doi.org/10.3390/molecules25102277
Naha S, Sands K, Mukherjee S, Roy C, Rameez MJ, Saha B et al (2020) KPC-2-producing Klebsiella pneumoniae ST147 in a neonatal unit: clonal isolates with differences in colistin susceptibility attributed to AcrAB-TolC pump. Int J Antimicrob Agents 55(3):105903. https://doi.org/10.1016/j.ijantimicag.2020.105903
Pérez-Boto D, Acebo P, García-Peña FJ, Abad JC, Echeita MA, Amblar M (2015) Isolation of a point mutation associated with altered expression of the CmeABC efflux pump in a multidrug-resistant Campylobacter jejuni population of poultry origin. J Glob Antimicrob Resist 3(2):115–122. https://doi.org/10.1016/j.jgar.2015.03.010
Ramadoss NS, Alumasa JN, Cheng L, Wang Y, Li S, Chambers BS et al (2013) Small molecule inhibitors of trans-translation have broad-spectrum antibiotic activity. Proc Natl Acad Sci USA 110(25):10282–10287. https://doi.org/10.1073/pnas.1302816110
Ren H, Liu Y, Zhou J, Long Y, Liu C, Xia B et al (2019) Combination of azithromycin and gentamicin for efficient treatment of Pseudomonas aeruginosa infections. J Infect Dis 220(10):1667–1678. https://doi.org/10.1093/infdis/jiz341
Ren H, Zhang J, Zhou J, Xu C, Fan Z, Pan X et al (2021) Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae. J Antibiot 74(8):528–537. https://doi.org/10.1038/s41429-021-00427-0
Rodrigues L, Aínsa JA, Viveiros M (2021) Measuring efflux and permeability in mycobacteria. Methods Mol Biol 2314:231–245. https://doi.org/10.1007/978-1-0716-1460-0_9
Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58(7):447–474
Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr (2004) Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38(9):1279–1286. https://doi.org/10.1086/420937
Svetlanov A, Puri N, Mena P, Koller A, Karzai AW (2012) Francisella tularensis tmRNA system mutants are vulnerable to stress, avirulent in mice, and provide effective immune protection. Molr Microbiol 85(1):122–141. https://doi.org/10.1111/j.1365-2958.2012.08093.x
Tait JR, Bilal H, Kim TH, Oh A, Peleg AY, Boyce JD et al (2021) Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model. J Glob Antimicrob Resist 26:55–63. https://doi.org/10.1016/j.jgar.2021.04.021
Tait JR, Bilal H, Rogers KE, Lang Y, Kim TH, Zhou J et al (2022) Effect of different piperacillin-tazobactam dosage regimens on synergy of the combination with tobramycin against Pseudomonas aeruginosa for the pharmacokinetics of critically ill patients in a dynamic infection model. Antibiotics 11(1):101. https://doi.org/10.3390/antibiotics11010101
Terbtothakun P, Nwabor OF, Siriyong T, Voravuthikunchai SP, Chusri S (2021) Synergistic antibacterial effects of meropenem in combination with aminoglycosides against carbapenem-resistant Escherichia coli harboring blaNDM-1 and blaNDM-5. Antibiotics 10(8):1023. https://doi.org/10.3390/antibiotics10081023
Vuotto C, Longo F, Pascolini C, Donelli G, Balice MP, Libori MF et al (2017) Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains. J Appl Microbiol 123(4):1003–1018. https://doi.org/10.1111/jam.13533
Walesch S, Birkelbach J, Jézéquel G, Haeckl FPJ, Hegemann JD, Hesterkamp T et al (2023) Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO Rep 24(1):e56033. https://doi.org/10.15252/embr.202256033
Yadav S, Singh AK, Agrahari AK, Pandey AK, Gupta MK, Chakravortty D et al (2021) Galactose-clicked curcumin-mediated reversal of meropenem resistance among Klebsiella pneumoniae by targeting its carbapenemases and the AcrAB-TolC efflux system. Antibiotics 10(4):388. https://doi.org/10.3390/antibiotics10040388
Funding
None.
Author information
Authors and Affiliations
Contributions
Wendong Fang (conceptualization, formal analysis, methodology, validation), Jie Xu (formal analysis, methodology, validation), Zilan Wei (methodology), Jiahui Wu (methodology), Weihui Wu (methodology, supervision, writing original draft), Youliang Wang (project administration, supervision, writing original draft), Shuiping Chen (methodology, project administration, supervision, writing original draft, writing review & editing).
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Communicated by Ran Wang.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fang, W., Xu, J., Wei, Z. et al. Enhancing bactericidal activities of ciprofloxacin by targeting the trans-translation system that is involved in stress responses in Klebsiella pneumoniae. Arch Microbiol 206, 154 (2024). https://doi.org/10.1007/s00203-024-03872-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00203-024-03872-1